COVID-19, Corrections, and Early-Release: Implications and Solutions for Populations with Opioid and Substance Use Disorders

13 Pages Posted: 24 Jan 2022

See all articles by Ernie Fletcher

Ernie Fletcher

Fletcher Group, Inc

Robin Thompson

Fletcher Group, Inc

Grace Clancy

Fletcher Group, Inc

David Johnson

Fletcher Group, Inc

Jennifer White

Fletcher Group, Inc

John Rees

Fletcher Group, Inc

Date Written: July 15, 2021

Abstract

As the United States continues to feel the weight of the delta variant, it is a time of reflection. This global pandemic serves as a reminder that infectious diseases pose an existential threat to our way of life and the way we operate institutions. Correctional facilities are one of many institutions that are high-risk environments and require a nuanced approach to policies and practices. Epidemic planning, as part of a robust disaster/crisis response, may include correctional early releases in order to reduce census and subsequent risk associated with congregate living. However, early release planning must equitably balance inherent risks that marginalized people face, including those with opioid and other substance use disorders (OUD/SUDs). The majority (80-85%) of individuals incarcerated have reported illicit substance use in their lifetime, but only 20% receive treatment while incarcerated. Releasing individuals with OUD/SUDs early due to COVID-19 or another epidemic or pandemic, without a robust reentry plan may result in a return to substance use, fatal and nonfatal drug overdose, and recidivism. This report describes the risks associated with this practice and provides comprehensive policy recommendations incorporating a COVID-19 risk assessment, considerations for OUD/SUD, mental health (MH), healthcare access and resources, recovery housing, and employment. COVID-19 variants and emerging infectious diseases pose an ongoing threat; therefore prevention/planning and response efforts should take place in all sectors. This policy may be adapted to future early release planning scenarios to adequately balance risk and support successful transitions.

Note:
Funding: This manuscript is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $10.4 million.

Declaration of Interests: None to declare.

Suggested Citation

Fletcher, Ernie and Thompson, Robin and Clancy, Grace and Johnson, David and White, Jennifer and Rees, John, COVID-19, Corrections, and Early-Release: Implications and Solutions for Populations with Opioid and Substance Use Disorders (July 15, 2021). Available at SSRN: https://ssrn.com/abstract=4004589 or http://dx.doi.org/10.2139/ssrn.4004589

Ernie Fletcher

Fletcher Group, Inc ( email )

London, KY 40701
United States

Robin Thompson (Contact Author)

Fletcher Group, Inc ( email )

London, KY 40701
United States

Grace Clancy

Fletcher Group, Inc ( email )

London, KY 40701
United States

David Johnson

Fletcher Group, Inc ( email )

London, KY 40701
United States

Jennifer White

Fletcher Group, Inc ( email )

London, KY 40701
United States

John Rees

Fletcher Group, Inc ( email )

London, KY 40701
United States

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Downloads
50
Abstract Views
547
PlumX Metrics